Dr Mireia Crispin-Ortuzar receives a Springboard Award to help unravel treatment response patterns in ovarian cancer.

April 19, 2023

Dr Mireia Crispin-Ortuzar, an Assistant Professor in Integrated Cancer Medicine at the University of Cambridge and co-lead of our Ovarian Cancer Programme, is a Springboard Awardee!
The grants will be used by researchers to advance medical science and translate developments into benefits for patients and the wider society.

From schemes that assist Professors moving to the UK, to grants that enable Clinicians to pursue research work, the Academy provides innovative career funding and support that strengthens the capacity of teams and outstanding individuals. Awardees also have access to the Academy’s one-to-one mentoring programme which provides researchers with career development support by pairing them with an Academy Fellow.

More than 40 Springboard Awards have been awarded to biomedical and health researchers in their first independent post to help launch their careers.

A total of more than £4million has been given to support research in areas as varied as seizures, obesity, and influenza to awardees based at a range of institutions.

Mireia’s research group focuses on integrating diverse data sets and developing machine learning models based on imaging and other types of data to predict how cancer patients will respond to treatment.

On receiving the Springboard Award, she said: “I am very excited to receive the Springboard Award from the Academy of Medical Sciences to investigate the multiscale complexity of ovarian cancer. “As part of the project we will generate a computational “atlas” of the disease that can help us identify which patients could benefit from different treatments based on their unique profiles extracted from imaging and molecular data.”

Dr Mireia Crispin-Ortuzar receives a Springboard Award to help unravel treatment response patterns in ovarian cancer.
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect